GlassScriptPhysician profile
Lisa Saintil
NPI 1174944094
$2,078.89
in general payments reported to CMS, 2019-2025
14 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $437 · 2023: $608 · 2024: $504 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $545.73 | 2021-2024 | Myrisk |
| Daiichi Sankyo INC. | $335.98 | 2022-2025 | Enhertu |
| Lilly USA, LLC | $182.78 | 2022-2023 | Verzenio |
| Tactile Systems Technology INC | $138.71 | 2024 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $127.39 | 2024 | Enhertu |
| Merck Sharp & Dohme LLC | $126.94 | 2023 | Lynparza, Keytruda |
| Elucent Medical | $126.67 | 2025 | |
| Seagen INC. | $124.99 | 2023 | Tukysa |
| Regeneron Healthcare Solutions, INC. | $111.76 | 2022 | |
| Janssen Biotech, INC. | $100.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $57.87 | 2022-2023 | |
| Ge Healthcare | $54.44 | 2025 | |
| Puma Biotechnology, INC. | $25.42 | 2025 | |
| Amgen INC. | $20.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Saintil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.